Published in G Ital Dermatol Venereol on February 01, 2013
Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease. Nat Genet (1999) 3.25
Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet (2000) 2.85
Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet (2005) 2.24
Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol (1998) 1.83
A marker for Stevens-Johnson syndrome ...: ethnicity matters. Pharmacogenomics J (2006) 1.73
The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation (1999) 1.67
Gene polymorphism in Netherton and common atopic disease. Nat Genet (2001) 1.66
A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet (1999) 1.65
Pachydermodactyly and atrophia maculosa varioliformis cutis. Dermatology (1995) 1.57
Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol (2015) 1.55
A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nat Genet (1993) 1.53
Calcium pumps and keratinocytes: lessons from Darier's disease and Hailey-Hailey disease. Br J Dermatol (2004) 1.49
A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet (1996) 1.47
Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. J Invest Dermatol (2000) 1.41
A truncating mutation in the laminin-332α chain highlights the role of the LG45 proteolytic domain in regulating keratinocyte adhesion and migration. Br J Dermatol (2014) 1.40
Distinctive integrin expression in the newly forming epidermis during wound healing in humans. J Invest Dermatol (1993) 1.39
'Matchstick' eyebrow hairs: a dermoscopic clue to the diagnosis of Netherton syndrome. J Eur Acad Dermatol Venereol (2009) 1.38
A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest (1997) 1.35
Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol (2001) 1.28
Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther (2002) 1.26
The role of CSA in the response to oxidative DNA damage in human cells. Oncogene (2007) 1.25
Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet (2000) 1.20
Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection. J Virol (1994) 1.18
The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J Invest Dermatol (2001) 1.16
Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping. Am J Hum Genet (2000) 1.15
Mosaicism for ATP2A2 mutations causes segmental Darier's disease. J Invest Dermatol (2000) 1.14
Keratitis-ichthyosis-deafness syndrome: disease expression and spectrum of connexin 26 (GJB2) mutations in 14 patients. Br J Dermatol (2007) 1.12
Selection of biologically active peptides by phage display of random peptide libraries. Curr Opin Biotechnol (1996) 1.12
Identification of a new locus for isolated familial keratoconus at 2p24. J Med Genet (2005) 1.10
Spectrum of novel ATP2A2 mutations in patients with Darier's disease. Hum Mol Genet (1999) 1.08
Congenital self-healing histiocytosis (Hashimoto-Pritzker). An ultrastructural and immunohistochemical study. Cancer (1988) 1.07
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther (1998) 1.07
Quality of life in patients with epidermolysis bullosa. Br J Dermatol (2009) 1.04
Direct detection of HIV-1 RNA in epidermal Langerhans cells of HIV-infected patients. J Acquir Immune Defic Syndr (1993) 1.02
Placenta growth factor is induced in human keratinocytes during wound healing. J Invest Dermatol (2000) 0.99
Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. J Acquir Immune Defic Syndr (1994) 0.96
Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol (2006) 0.96
Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies. J Dermatol (1994) 0.96
The 100-kDa 2',5'-oligoadenylate synthetase catalyzing preferentially the synthesis of dimeric pppA2'p5'A molecules is composed of three homologous domains. J Biol Chem (1999) 0.95
Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa. Gene Ther (2010) 0.94
Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV. AIDS Res Hum Retroviruses (1989) 0.94
Apoptosis and efficient repair of DNA damage protect human keratinocytes against UVB. Cell Death Differ (2003) 0.93
Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa. Hum Gene Ther (1998) 0.93
Expression of an estrogen receptor-associated protein (p29) in epithelial tumors of the skin. J Cutan Pathol (1989) 0.93
Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur J Immunol (1997) 0.92
Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis. Cell Death Dis (2012) 0.91
New type of epidermal nevus syndrome. Dermatology (2000) 0.91
A sequence-ready physical map of a region of 12q24.1. Genomics (1997) 0.91
PCR-based detection of two exonic polymorphisms in the human type VII collagen gene (COL7A1) at 3p21.1. Genomics (1992) 0.91
Involucrin expression in keratinization disorders of the skin--a preliminary study. Br J Dermatol (1987) 0.90
Premature termination codon mutations in the type VII collagen gene (COL7A1) underlie severe recessive dystrophic epidermolysis bullosa. Proc Assoc Am Physicians (1995) 0.90
Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage. Virology (2001) 0.89
Lethal autosomal recessive epidermolytic ichthyosis due to a novel donor splice-site mutation in KRT10. Br J Dermatol (2010) 0.89
In vitro infection of human epidermal Langerhans' cells with HIV-1. Immunology (1995) 0.89
[A lethal variant of Netherton syndrome in a large inbred family]. Arch Pediatr (2011) 0.89
Association of piebaldism and neurofibromatosis type 1 in a girl. Pediatr Dermatol (2002) 0.88
Genomic structure, promoter characterisation and mutational analysis of the S100A7 gene: exclusion of a candidate for familial psoriasis susceptibility. Hum Genet (1999) 0.88
Acral self-healing collodion baby: report of a new clinical phenotype caused by a novel TGM1 mutation. Br J Dermatol (2009) 0.87
Induction of senescence pathways in Kindler syndrome primary keratinocytes. Br J Dermatol (2013) 0.87
Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. J Invest Dermatol (1994) 0.86
Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis. J Invest Dermatol (1994) 0.86
Clouston hidrotic ectodermal dysplasia (HED): genetic homogeneity, presence of a founder effect in the French Canadian population and fine genetic mapping. Eur J Hum Genet (2000) 0.86
Compound heterozygosity for an out-of-frame deletion and a splice site mutation in the LAMB3 gene causes nonlethal junctional epidermolysis bullosa. Biochem Biophys Res Commun (1998) 0.86
Beta 1 and beta 3 integrin upregulation in rapidly progressive glomerulonephritis. Nephrol Dial Transplant (1995) 0.85
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa. Hum Gene Ther (2000) 0.85
The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation. Br J Dermatol (2010) 0.84
Genitoperineal papular acantholytic dyskeratosis is allelic to Hailey-Hailey disease. Br J Dermatol (2012) 0.84
Early skin biopsy is helpful for the diagnosis and management of neonatal and infantile erythrodermas. J Cutan Pathol (2009) 0.84
Three novel point mutations in the keratinocyte transglutaminase (TGK) gene in lamellar ichthyosis: significance for mutant transcript level, TGK immunodetection and activity. Eur J Hum Genet (1998) 0.84
A glutamine insertion in the 1A alpha helical domain of the keratin 4 gene in a familial case of white sponge nevus. J Invest Dermatol (2000) 0.84
Olmsted syndrome with erythromelalgia caused by recessive transient receptor potential vanilloid 3 mutations. Br J Dermatol (2014) 0.84
Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression. Br J Dermatol (2011) 0.83
Delayed diagnosis of dyskeratosis congenita in a 40-year-old woman with multiple head and neck squamous cell carcinomas. Br J Dermatol (2007) 0.83
Circumscribed palmo-plantar hypokeratosis: a disease of desquamation? Immunohistological study of five cases and literature review. J Eur Acad Dermatol Venereol (2011) 0.83
Confirmation of linkage of Clouston syndrome (hidrotic ectodermal dysplasia) to 13q11-q12.1 with evidence for multiple independent mutations. J Invest Dermatol (1998) 0.83
Novel mutations in the LAMC2 gene in non-Herlitz junctional epidermolysis bullosa: effects on laminin-5 assembly, secretion, and deposition. J Invest Dermatol (2001) 0.83
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Ann Hum Genet (2004) 0.83
New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. Clin Exp Rheumatol (2006) 0.82
Different phenotypes in recessive dystrophic epidermolysis bullosa patients sharing the same mutation in compound heterozygosity with two novel mutations in the type VII collagen gene. Br J Dermatol (2002) 0.82
ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum. Eur J Biochem (2001) 0.82
Expression of neural-tissue markers (S-100 protein and Leu-7 antigen) by sweat gland tumors of the skin. An immunohistochemical study. J Am Acad Dermatol (1987) 0.82
Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients. Br J Dermatol (2004) 0.82
Beta-1 integrins in the normal human glomerular capillary wall: an immunoelectron microscopy study. Nephron (1994) 0.82
Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa. J Invest Dermatol (1998) 0.82
Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex. Br J Dermatol (2011) 0.82
Severe hypernatremic dehydration in an infant with Netherton syndrome. Genet Couns (2001) 0.81
Free radical production during metabolism of organic hydroperoxides by normal human keratinocytes. J Invest Dermatol (1993) 0.81
Characterization of the gene encoding the 100-kDa form of human 2',5' oligoadenylate synthetase. Genomics (2000) 0.81
Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study. Arch Dermatol (1992) 0.81
Human epidermal basal keratinocytes express CDw29 antigens. Br J Dermatol (1989) 0.81
Antibodies against sialophorin (CD43) enhance the capacity of dendritic cells to cluster and activate T lymphocytes. J Immunol (1997) 0.81
Eccrine syringofibroadenoma. Immunohistological study of a new case. Am J Dermatopathol (1987) 0.81
Stable integration of large (>100 kb) PAC constructs in HaCaT keratinocytes using an integrin-targeting peptide delivery system. Gene Ther (2000) 0.80
Cutaneous phaeohyphomycosis due to Cladosporium cladosporioides. Mycoses (1993) 0.80
Novel and recurrent mutations in the integrin beta 4 subunit gene causing lethal junctional epidermolysis bullosa with pyloric atresia. Exp Dermatol (2003) 0.80
Immunohistochemistry of cutaneous graft-versus-host disease after allogeneic bone marrow transplantation. J Dermatol (1991) 0.80
A homozygous nonsense mutation in type XVII collagen gene (COL17A1) uncovers an alternatively spliced mRNA accounting for an unusually mild form of non-Herlitz junctional epidermolysis bullosa. J Invest Dermatol (2001) 0.79
Role of Sp1 response element in transcription of the human transglutaminase 1 gene. J Invest Dermatol (2000) 0.79